Nuwellis (NUWE)
NASDAQ:NUWE
Want to see NUWE full AI Analyst Report?
Earnings Data
Report Date
Aug 11, 2026TBA (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
-0.68Last Year’s EPS
-60.99Same Quarter Last Year
Based on 1 Analysts Ratings
Earnings Call Summary
Q1 2026
Earnings Call Date:May 12, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented multiple positive operational and strategic developments (notably 26% revenue growth, a 70.1% gross margin, pediatric adoption, the RendiaTech acquisition, a new patent, leadership and board strengthening, and a ~$5M capital infusion). However, notable challenges remain: a ~$4.3M net loss, operating expenses up ~46%, modest cash on hand (~$2.2M), and a multi-quarter timeline to commercialize RendiaTech's target product. On balance, the highlights indicate meaningful early execution progress and strategic positioning, but the company must deliver on its burn reduction and commercialization milestones to sustain momentum.Company Guidance
Revenue Growth
Q1 2026 revenue was $2.4 million, up 26% year-over-year from $1.9 million, driven by stronger console and circuit sales.
Console and Circuit Sales Momentum
The company sold 15 Aquadex consoles in the quarter (including upgrades) and reported a 15% increase in circuit sales, reflecting continued growth in patients treated with Aquadex therapy.
Gross Margin Improvement
Gross margin improved to 70.1% in Q1 2026, a 14% increase year-over-year, attributed to improved pricing, favorable product mix, and transition to contract manufacturing (KDI).
Pediatric Commercial Traction
Pediatrics now represent ~50% of total U.S. revenue; pediatric footprint expanded to 47 centers nationwide, including placements at 6 of the top children's hospitals — validating pediatrics as a clear growth category.
Strategic Acquisition and Product Expansion
Completed the acquisition of RendiaTech (March 2026) to add automated kidney function monitoring capabilities to the cardiorenal platform, broadening clinical value around precision fluid removal and earlier kidney insight.
Intellectual Property and Clinical Leadership
Issued a new U.S. patent supporting advanced safety design for pediatric extracorporeal therapy (supporting the Vivien pediatric CRRT system in development) and appointed Dr. Stuart Goldstein as director of clinical strategy.
Strengthened Leadership, Board, and Field Sales
Appointed Carisa Schultz as CFO, added Martin Emerson to the board and reappointed David McDonald; returned three experienced sales leaders and expanded coverage (e.g., new South Texas territory) to support commercialization.
Capital and Balance Sheet Actions
Completed approximately a $5 million private placement and warrant inducement transaction, and reports no debt on the balance sheet as of 03/31/2026 (cash and restricted cash ~ $2.2 million).
Operational Discipline Target
Announced a cash burn reduction plan intended to reduce monthly cash burn by approximately 50% by Q4 2026 while focusing resources on high-value commercial areas.
NUWE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
NUWE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2026 | $1.04 | $1.03 | -0.96% |
Mar 10, 2026 | $1.29 | $1.30 | +0.78% |
Nov 12, 2025 | $2.78 | $2.67 | -3.96% |
Aug 14, 2025 | $5.50 | $5.64 | +2.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Nuwellis (NUWE) report earnings?
Nuwellis (NUWE) is schdueled to report earning on Aug 11, 2026, TBA (Confirmed).
What is Nuwellis (NUWE) earnings time?
Nuwellis (NUWE) earnings time is at Aug 11, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is NUWE EPS forecast?
NUWE EPS forecast for the fiscal quarter 2026 (Q2) is -0.68.